Cardica, Inc. (NASDAQ:CRDC) will announce its earnings results on Thursday, February 4th. Investors that are interested in registering for the company’s conference call can do so using this link.

Cardica (NASDAQ:CRDC) last announced its quarterly earnings data on Thursday, November 5th. The company reported ($0.05) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.05). On average, analysts expect Cardica to post $-0.19 EPS for the current fiscal year and $-0.19 EPS for the next fiscal year.

Cardica, Inc. (NASDAQ:CRDC) opened at 0.31 on Tuesday. The stock’s 50 day moving average is $0.19 and its 200 day moving average is $0.27. Cardica, Inc. has a one year low of $0.11 and a one year high of $0.66. The stock’s market capitalization is $27.60 million.

CRDC has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded shares of Cardica from a “hold” rating to a “buy” rating and set a $0.25 price objective on the stock in a research note on Wednesday, October 21st. Wedbush reaffirmed a “buy” rating and set a $1.50 target price on shares of Cardica in a report on Tuesday, October 6th.

Cardica, Inc. is focused on the commercialization and development of microcutter product line intended for use by thoracic, bariatric, colorectal and general surgeons. The microcutter product line consists of the commercially-available MicroCutter XCHANGE 30 and products in development, including the MicroCutter XCHANGE 45, the MicroCutter FLEXCHANGE 30 and the MicroCutter XPRESS 45. The Company’s business focuses on the design, manufacture and marketing of automated anastomotic systems used by cardiac surgeons to perform coronary bypass surgery. Its C-Port Distal Anastomosis Systems, or C-Port systems, are sold in the United States and Europe. The C-Port systems are used to perform a distal anastomosis, which is the connection between a bypass graft vessel and the target coronary artery. The PAS-Port system is used to perform a proximal anastomosis, which is the connection of a bypass graft vessel to the aorta or other source of blood.

12 Month Chart for NASDAQ:CRDC

Receive News & Ratings for Cardica Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardica Inc. and related companies with MarketBeat.com's FREE daily email newsletter.